MODD
Modular Medical, Inc. NASDAQ Listed Feb 10, 2022$4.60
-1.71%
vs $4.68
Mkt Cap $5.7M
52w Low $3.30
6.7% of range
52w High $22.83
50d MA $4.41
200d MA $10.61
P/E (TTM)
-0.3x
EV/EBITDA
—
P/B
0.3x
Debt/Equity
0.1x
ROE
-363.5%
P/FCF
-0.3x
RSI (14)
46.80
ATR (14)
$0.83
Beta
-0.00
50d MA
$4.41
200d MA
$10.61
Avg Volume
91.0K
Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.
16772 W. Bernardo Drive · San Diego, CA 92127 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | AMC | -3.00 | -3.30 | -10.0% | 13.75 | -0.4% | -1.6% | +12.9% | -3.3% | -1.1% | -3.2% | — |
| Nov 14, 2025 | AMC | -0.10 | -0.14 | -40.0% | 16.00 | +1.4% | -2.6% | -2.1% | -3.5% | -9.0% | -0.6% | — |
| Aug 14, 2025 | AMC | -0.10 | -0.12 | -20.0% | 22.11 | -1.6% | -2.3% | -2.6% | -0.1% | +1.4% | -1.4% | — |
| Jun 20, 2025 | AMC | -0.11 | -0.12 | -9.1% | 22.80 | +0.0% | +2.9% | +1.0% | +2.5% | -19.9% | +4.6% | — |
| Feb 13, 2025 | AMC | -0.12 | -0.13 | -8.3% | 34.50 | -2.6% | -4.3% | +0.9% | +0.0% | -1.8% | -0.9% | — |
| Nov 14, 2024 | AMC | -0.14 | -0.14 | +0.0% | 64.20 | -0.9% | -3.3% | +1.4% | +0.0% | -1.9% | -5.8% | — |
| Aug 13, 2024 | AMC | -0.12 | -0.12 | +0.0% | 49.50 | -0.6% | +5.5% | -2.9% | +0.6% | +0.0% | +0.6% | — |
| Jun 21, 2024 | AMC | -0.20 | -0.14 | +30.0% | 44.40 | +6.8% | +4.7% | +0.0% | +3.2% | -2.5% | +1.3% | — |
| Feb 13, 2024 | AMC | -0.17 | -0.23 | -35.3% | 38.10 | +12.6% | -10.2% | +9.6% | +40.0% | +0.0% | +1.1% | — |
| Nov 13, 2023 | AMC | -0.19 | -0.19 | +0.0% | 35.10 | -3.4% | -2.6% | -1.2% | -6.7% | -1.9% | -1.9% | — |
| Aug 14, 2023 | AMC | -0.22 | -0.22 | +0.0% | 31.50 | -1.9% | +0.0% | -6.7% | +1.8% | +22.2% | +6.6% | — |
| Jun 26, 2023 | AMC | -0.34 | -0.33 | +2.9% | 29.88 | +0.3% | +2.4% | -4.9% | -3.6% | +4.8% | +1.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 21 | Benchmark | Maintains | Speculative Buy → Speculative Buy | — | $58.50 | $58.50 | +0.0% | -2.6% | +2.6% | +1.5% | -2.0% | +0.5% |
| Sep 19 | Oppenheimer | Maintains | Outperform → Outperform | — | $34.80 | $34.80 | +0.0% | +0.0% | -0.9% | +1.7% | -0.9% | -5.2% |
| Jun 30 | Benchmark | Maintains | Speculative Buy → Speculative Buy | — | $28.05 | $30.30 | +8.0% | +4.8% | +1.8% | -8.6% | +11.8% | -6.3% |
| May 19 | Oppenheimer | Maintains | Outperform → Outperform | — | $28.50 | $29.70 | +4.2% | +8.4% | -4.5% | +7.7% | +0.9% | -0.9% |
| Jan 30 | Benchmark | Maintains | Speculative Buy → Speculative Buy | — | $75.00 | $69.30 | -7.6% | -4.0% | +0.0% | +0.0% | +1.7% | +3.7% |
| Apr 8 | Lake Street | Maintains | Buy → Buy | — | $126.90 | $126.90 | +0.0% | -1.2% | -6.9% | +3.6% | +2.0% | +3.2% |
| Mar 25 | Benchmark | Maintains | Speculative Buy → Buy | — | $120.00 | $133.80 | +11.5% | +6.2% | -2.4% | +8.9% | -7.5% | +5.3% |
No insider trades available.
8-K · 5.02
!!! Very High
Modular Medical, Inc. -- 8-K 5.02: Executive Change
Modular Medical appointed a new director, signaling potential strategic shifts in governance that investors should monitor for impacts on company operations and decision-making.
May 20
8-K · 1.01
!! High
Modular Medical, Inc. -- 8-K 1.01: Material Agreement
Modular Medical secured $3.375 million in financing through a placement agency agreement with Maxim Group LLC, providing capital for operations and growth initiatives.
Apr 21
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Delisting risk eliminated as stock rebounds above $1.00 minimum bid price, allowing the company to continue trading on Nasdaq and avoiding forced market downgrade.
Apr 16
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
MODD's reverse stock split announcement suggests potential financial distress or Nasdaq compliance issues, which typically dilutes shareholder value and signals operational challenges requiring investor scrutiny.
Mar 31
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
MODD's 8-K disclosure lacks material business substance, suggesting a potential shell company or administrative filing with minimal operational significance for investors evaluating fundamental business changes.
Mar 13
8-K · 1.01
!! High
Modular Medical, Inc. -- 8-K 1.01: Material Agreement
Modular Medical secured a $12 million agreement with Maxim Group LLC, potentially involving financing or a strategic partnership that could strengthen the company's capital position.
Mar 6
8-K · 1.01
! Medium
Modular Medical, Inc. -- 8-K 1.01: Financing / Debt Agreement
Modular Medical secured a $350,000 revolving credit facility from CEO Besser at 12% interest, maturing March 2026, providing near-term liquidity but indicating potential financial constraints.
Feb 24
Institutional (13F) — Top 4
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 55,917 | $295K | New | Mar 2026 |
| 2 | Heights Capital Management, Inc | 50,000 | $264K | New | Mar 2026 |
| 3 | Ubs Group Ag | 623 | $3K | New | Mar 2026 |
| 4 | Western Wealth Management, Llc | 66 | $348 | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 1
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF | 6,599 | $35K | Mar 2026 |
Valuation
Market Cap
$5.7M
Enterprise Value
-$7.4M
P/E (TTM)
-0.31x
Forward P/E
—
PEG Ratio
0.06x
P/B
0.33x
P/S
—
P/FCF
-0.31x
EV/EBITDA
—
Shares Out
1.2M
Financials (TTM)
Revenue
$0
Net Income
-$26.8M
EBITDA
-$25.2M
Free Cash Flow
-$18.2M
Op Cash Flow
-$15.7M
EPS Basic
$-15.30
EPS Diluted
$-14.70
EPS Forward
$-17.10
Gross Margin
—
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$18.7M
Total Liab.
$1.7M
Total Equity
$17.1M
Cash
$13.1M
LT Debt
$0
Book Value/Sh
$13.84
Debt/Equity
0.05x
Current Ratio
10.69
Quick Ratio
10.69
Returns & Growth
ROE
-363.5%
ROA
-208.4%
ROIC
-106.5%
Rev Growth YoY
+0.0%
EPS Growth YoY
+34.6%
Price Returns
2W
+3.1%
1M
-1.9%
3M
-17.0%
6M
-60.2%
12M
-79.0%
Technicals
52W High
$22.83
52W Low
$3.30
50d MA
$4.41
200d MA
$10.61
RSI (14)
46.80
ATR (14)
$0.83
Beta
-0.00
Avg Volume
91K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 26, 2026 12:56pm
· Source: financialmodelingprep.com